Jade Biosciences, Inc.·4

May 19, 4:54 PM ET

Frohlich Tom 4

4 · Jade Biosciences, Inc. · Filed May 19, 2025

Insider Transaction Report

Form 4
Period: 2025-05-16
Frohlich Tom
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2025-05-16$7.40/sh+6,000$44,4006,000 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4